Bill Sponsors: US SB2665 | 2017-2018 | 115th Congress

Bill Title: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2018-04-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB2665 Detail]

Text: Latest bill text (Introduced) [PDF]

Sponsors

NameTypeSponsorshipDistrictFinancialFinancialEncyclopediaBiographyBioGuide
Senator Todd Young [R]PrimarySponsored BillsSD-INOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Senator Joe Donnelly [D]CosponsorSponsored BillsSD-INOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide

Social Comments on US SB2665

feedback